International Conference on Dementia and Brain Disorders & 2nd International Conference on Neurology & Neurological Disorders

November 15, 2024 | Virtual Event

Cognitive Impairment in Multimorbid Elderly Patients with Hypertension and Chronic Kidney Disease

Kantemir Dzamikhov

Russian Medical Academy of Continuous Professional Education, Russia

Biography :

Kantemir Dzamikhov – researcher, physician at the Russian Medical Academy of Continuous Professional Ed­ucation (Department of therapy and multimorbid pathology named after academician M.S. Vovsi). Has publi­cations in Russian and International journals in the scientific direction: cognitive impairment in elderly patients. Member of the Russian Scientific Society of Internal Medicine (RSMSIM), European Federation of Internal Med­icine Academy (EFIM Academy).

Abstract :

Aim: To assess cognitive functions in elderly patients with arterial hypertension (AH) and con­comitant chronic kidney disease (CKD).

Methods: Three groups were formed according to medical records data: 1) patients with AH (n=110, median age 76 [69,8;82,3] years), 2) patients with AH and CKD stage 3a (n=110, me­dian age 81[73,8;84,3] years), 3) patients with AH and CKD stage 3b (n=110, median age 79,5 [72;85,3] years). Cognitive assessment included MMSE, MoCA, DSST, VFT, ADAS-cog.

Findings: Patients with AH and CKD stage 3b had significantly lower MMSE и MoCA scores (26 [24;28,3] and 23 [21;25] points) compared to group 1 (28 [25,8;29] and 24 [22;26] points; p=0.001 and p=0.034). Similarly, group 3 had significantly lower DSST scores (19 [17;22]) com­pared to group 1 (21,5 [19;25]; p=0.045). VFT showed significantly lower verbal fluency in group 3 compared to group one - 12 [11;13] and 11 [10;13] words, respectively (p=0.003). Group 3 had significantly higher ADAS-Cog score (15,5 [11;19]) compared to group 1 (11 [9;15]; p<0,001) and group 2 (13,5 [10;17]; p=0.029).

Results: Multimorbidity in the form of the concomitant CKD in patients with AH may contrib­ute to the development of more prominent cognitive impairment, deterioration of executive function, semantic memory, as well as attention, visual-spatial ability, and working memory. These correlations may become more pronounced with the increasing severity of CKD